JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.51B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$818M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$596M |
| 4 |
Eaton
ETN
|
+$577M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 3 |
Starbucks
SBUX
|
+$679M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$565M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.34% |
| 2 | Technology | 11.83% |
| 3 | Healthcare | 9.48% |
| 4 | Consumer Discretionary | 7.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFF
2576
DELISTED
EATON VANCE FLOATING-RATE INCOME PLUS FUND
EFF
| $4.07M | ﹤0.01% |
245,325
+3,476
| +1% | +$58K |
|
2577
Fresenius Medical Care
FMS
$12.6B
| $4.06M | ﹤0.01% |
83,586
-3,543
| -4% | -$168K |
|
2578
PDS Biotechnology
PDSB
$13M
| $4.06M | ﹤0.01% |
18,954
+13,093
| +223% | +$2.71M |
|
|
PRTK
2579
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $4.05M | ﹤0.01% |
160,781
-38,944
| -19% | -$906K |
|
|
FTR
2580
PUT
DELISTED
Frontier Communications Corp.
FTR
| $4.04M | ﹤0.01% |
328,634
+263,534
| +405% | +$3.7M |
|
|
MCHB
2581
Mechanics Bancorp
MCHB
$3.79B
| $4.04M | ﹤0.01% |
151,600
-4,900
| -3% | -$128K |
|
2582
Argan
AGX
$7.84B
| $4.04M | ﹤0.01% |
60,334
-2,840
| -4% | -$178K |
|
2583
CALL
Eli Lilly
LLY
$1.08T
| $4.04M | ﹤0.01% |
47,500
+45,200
| +1,965% | +$3.71M |
|
2584
KALA BIO
KALA
$17.9M
| $4.04M | ﹤0.01% |
+70
| New | +$3.84M |
|
2585
Cenovus Energy
CVE
$56.4B
| $4.03M | ﹤0.01% |
397,571
+12,695
| +3% | +$104K |
|
|
BRFS
2586
PUT
DELISTED
BRF SA
BRFS
| $4.01M | ﹤0.01% |
+280,500
| New | +$3.65M |
|
|
QHC
2587
DELISTED
Quorum Health Corporation
QHC
| $4.01M | ﹤0.01% |
815,934
+114,525
| +16% | +$466K |
|
|
NVRO
2588
PUT
DELISTED
NEVRO CORP.
NVRO
| $4M | ﹤0.01% |
+45,000
| New | +$3.85M |
|
2589
CALL
US Bancorp Series B Preferred Stock
USB.PRH
$743M
| $3.99M | ﹤0.01% |
74,600
-21,300
| -22% | -$506K |
|
|
PDCE
2590
DELISTED
PDC Energy, Inc.
PDCE
| $3.99M | ﹤0.01% |
81,398
-14,868
| -15% | -$640K |
|
|
KDNY
2591
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $3.99M | ﹤0.01% |
73,190
-1,280
| -2% | -$76.1K |
|
|
CADE
2592
DELISTED
Cadence Bancorporation
CADE
| $3.98M | ﹤0.01% |
174,287
+57,825
| +50% | +$1.26M |
|
2593
Astec Industries
ASTE
$975M
| $3.97M | ﹤0.01% |
69,886
+7,039
| +11% | +$359K |
|
|
AYX
2594
DELISTED
Alteryx Inc
AYX
| $3.97M | ﹤0.01% |
194,300
+140,700
| +263% | +$2.98M |
|
2595
Compañía de Minas Buenaventura
BVN
$8.55B
| $3.97M | ﹤0.01% |
303,075
-89,318
| -23% | -$1.13M |
|
|
BMS
2596
CALL
DELISTED
Bemis
BMS
| $3.97M | ﹤0.01% |
+87,500
| New | +$3.9M |
|
|
COUP
2597
DELISTED
Coupa Software Incorporated
COUP
| $3.96M | ﹤0.01% |
128,677
+78,477
| +156% | +$2.39M |
|
|
BRKL
2598
DELISTED
Brookline Bancorp
BRKL
| $3.95M | ﹤0.01% |
256,635
-5,504
| -2% | -$79.8K |
|
|
BSFT
2599
DELISTED
BroadSoft, Inc.
BSFT
| $3.95M | ﹤0.01% |
78,855
+72,344
| +1,111% | +$3.3M |
|
|
TRK
2600
DELISTED
Speedway Motorsports, Inc.
TRK
| $3.94M | ﹤0.01% |
183,471
-32,678
| -15% | -$658K |
|
Similar funds
JP Morgan Chase's Q3 2017 Portfolio in Review
As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2017 filing shows 502 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
- JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
- JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
- JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
- JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
- JP Morgan Chase opened 502 new positions and closed 470 in Q3 2017.
- JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.